Skip to content
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
Menu
  • Pα+
Search
Join Pα+
  • Sign in
Menu
  • Sign in
Join Pα+
Search
Close this search box.
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Join Pα+
Search
Close this search box.
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Read more about the article Psychedelic Bulletin: MindMed Raises $28.75m, Entheon Inches Closer to Go-Public, Next Week’s Votes on Decriminalisation

Psychedelic Bulletin: MindMed Raises $28.75m, Entheon Inches Closer to Go-Public, Next Week’s Votes on Decriminalisation

  • Post published:October 30, 2020
  • Post category:Psychedelic Bulletin
Read more about the article Psychedelic Bulletin: Cybin Raises $45m, Numinus Harvests Psilocybe Mushrooms, New Psilocybin Clinical Trial

Psychedelic Bulletin: Cybin Raises $45m, Numinus Harvests Psilocybe Mushrooms, New Psilocybin Clinical Trial

  • Post published:October 23, 2020
  • Post category:Psychedelic Bulletin
Read more about the article Psychedelic Bulletin: Swedish Psilocybin for Depression Trial Launches; Numinus Appoints Advisory Council Members; Field Trip Announces Partnership

Psychedelic Bulletin: Swedish Psilocybin for Depression Trial Launches; Numinus Appoints Advisory Council Members; Field Trip Announces Partnership

  • Post published:October 17, 2020
  • Post category:Psychedelic Bulletin
Read more about the article Psychedelic Bulletin: Field Trip Lists on the CSE; MindMed Partners with NYU; Zuckerberg Supports Decriminalisation

Psychedelic Bulletin: Field Trip Lists on the CSE; MindMed Partners with NYU; Zuckerberg Supports Decriminalisation

  • Post published:October 9, 2020
  • Post category:Psychedelic Bulletin

End of content

No more pages to load

← Newer Posts

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

  • Insights
  • Jobs
  • Data
  • Subscribe to Pα+
  • Contact

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

Subscribe to Pα+
  • Psychedelic Alpha © 2025, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Subscribe to Our Free Newsletter

Join Pα+ for Premium Insights

Subscribe Annually ($200)
Subscribe Monthly ($20)
Learn More